Efficacy of Ashwagandha (withania somnifera [l.] Dunal) in improving cardiorespiratory endurance (VO2 max test) in healthy subjects
Abstract
In Ayurveda, certain herbal formulas are considered to be Rasayana and they are typically taken over periods of time to regenerate both brain and body tissue. Ashwagandha (Withania Somnifera) is used as an adaptogen, antioxidant, immune modulator, free radical scavenger, anti stress, anti arthritic, antispasmodic, anti inflammatory, nervous tonic, nerve soothing and anticancer agent. Ashwagandha (WS) as a nutritional supplement is yet too established. Maximum oxygen uptake (VO2 max) is a gold standard of cardiopulmonary and muscle cell fitness is considered. The study evaluated the efficacy of Ashwagandha to improve cardiorespiratory endurance (VO2 max) in healthy subjects. They randomized single blind controlled comparative clinical study. 54 health volunteers in each group, study group received Ashwagandha Choorna 12gm with milk (200ml) empty stomach in the morning and the control group only milk (200ml). Maximal capacity of oxygen intake in ml/kg/min (VO2 max) with Rockport fitness walking test of both study and control group were measured before intervention (0th day), after the intervention (60th day) and follow up (90th day). A significant improvement in the VO2 max (F=20.675, P <0.0001) and Hemoglobin (X2=74.150 P <0.0001) in the study group was found. Supplementation of Ashwagandha (Withania Somnifera) with milk improve hemoglobin and VO2 max (maximum aerobic capacity).
Keywords
Ashwagandha, Cardiorespiratory Endurance, Haemoglobin, Physical Fitness, VO2 Max (Maximal Aerobic Capacity), Withania Somnifera
Introduction
Ayurveda is widely used in India as a primary health care system and is flourishing in the promotion of health worldwide. Ayurveda aims to make society happy, healthy and peaceful. In general, the simple regimes mentioned in Ayurveda texts are of immense use faced by the present world today regarding health promotion (Sharma, 1999). As a society, our physical appearance is of growing importance to us. In developing countries, for example, as many as 24 percent of individuals admittedly exercise to enhance their performance. Professional men and amateurs are constantly searching for new ways that will help them to produce better results
in less time. Among means, dietary supplements belong to a prominent position. However, manufacturers also market goods which are neither evidence based nor safe for use in sport. This makes the use of herbal supplements to be irrational, which often leads to unwanted side effects but is more frequently of no use (Končić, 2018; Sangwan, 2004). In traditional Indian systems of medicine, one of the most common plants is Ashwagandha (Withania Somnifera Dunal), also referred to as winter cherry (Bhandari, 1970).
Ashwagandha (WS) has the property of Rasayana as mentioned in literature. It not only maintains the equilibrium of Dosha and Dhatu of the body but also promotes health. Ashwagandha is Vatakaphahara, Jara Vyadhi Nashaka, Balya and Dhatu Vriddhikara properties. Because of these properties, it shows not only preventive but also promotive and curative effects as well as slowdown Jara by breaking the pathogenesis. Ashwagandha (WS) maintains the positive health, enhance the quality of life, cures morbid sleep, drowsiness, physical and mental fatigue, laziness weakness, and preserves youthness. In Ayurveda, Unani and Siddha, this plant is used in more than 200 formulations. One of the prime drugs of Ashwagandha is Medica Ayurveda Material (Chunekar & Pandey, 2010; Mishra, 2000; Sharma, 2001).
Physical fitness is defined as a degree to execute a physical activity under different environmental conditions. It has five components aerobic capacity, muscular endurance, flexibility and body composition. The gold standard of cardiopulmonary and muscle cell fitness is considered to be maximum oxygen intake. The maximum oxygen uptake (VO2 max) is the highest oxygen consumption rate that can be reached during maximum or exhaustive exercises (Setty, 2013).
Objective
The study evaluated the efficacy of Ashwagandha to improve cardiorespiratory endurance (VO2 max test) in healthy subjects.
Materials and Methods
This is randomized, single blind controlled comparative study with pretest and post test design was approved by Institutional Ethics committee Sri Dharmasthala Manjunatheshwara College of Ayurveda and hospital, Hassan, Karnataka, India (IEC No: SDM/IEC/92/2016-2017 dt.25 June 2016) and the study was conducted in compliance with good clinical practice guidelines, declaration of Helsinki and all other applicable regulations. CTRI no- 2019/05/019009.
Source of data
Apparently healthy subjects from OPD of Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Hassan either gender who are fulfilling the criteria of inclusion are selected irrespective of gender and caste etc.
Method of collection of data (including sampling procedure, if any) Survey
408 apparently healthy subjects were screened for the features of Arogya (health). 108 apparently healthy subjects were selected by considering the inclusion criteria.
Criteria for selection of subjects
Inclusion criteria
Apparently Healthy subjects who were interested and willing to take Ashwagandha (Withania Somnifera) and subjects of age group 18-40 yrs.
Exclusion criteria
Pregnant women, lactating women etc.
Duration of the study
60 days for both study and control groups.
Follow up
After one month of completion on intervention.
Intervention
Randomly divided into two groups, Group 1 (control group) and Group 2 (study group).
Group 1
In 54 subjects administered 2 Haritaki tablets for Kostha Shuddhi (proper cleansing of stool) with hot water for a minimum of 3 days and 200 ml milk (Dugdha) for 60 days in empty stomach early in the morning kept as a control.
Group 2
In 54 subjects administered 2 Haritaki tablets for Kostha Shuddhi (proper cleansing of stool) with hot water for a minimum of 3 days and 12gm of Ashwagandha Choorna with 200 ml milk (Dugdha) for 60 days in empty stomach early in the morning.
Medicine Name
Ashwagandha Choorna (Withania Somnifera powder)
Study Design
108 apparently healthy subjects were selected for a clinical study. During the study periods, the subjects visited the study center at screening and enrollment and after 60th day at the completion of the trial.
Patient Enrollment |
|
---|---|
Screening for eligibility = Total 408 Subjects |
|
Total subjects selected = 114 subjects |
|
Randomized (n=114) |
|
Allocated in Group 1 (n=57) |
Allocated in Group 2 (n=57) |
Baseline evaluation (n=57) |
Baseline evaluation (n=57) |
Evaluation after intervention 60 days (n=54) Dropout (3 subjects) |
Evaluation after intervention 60 days (n=54) Dropout (3 subjects) |
Follow up 90 day (n=54) |
Follow up 90 day (n=54) |
Efficacy Analysis of Ashwagandha (n=54) |
Efficacy Analysis of Ashwagandha (n=54) |
Haemoglobin |
N |
Mean |
Std. Deviation |
---|---|---|---|
Before intervention (0th day) |
54 |
13.4315 |
.66696 |
After intervention (60th day) |
54 |
13.5481 |
.46974 |
Follow up (90th day ) |
54 |
13.2019 |
.51487 |
Estimation of VO2 max - Rock port fitness walking test
VO2 max is a measure of the maximum amount of oxygen that we use during intense physical exercise. To test VO2 max, there are many methods you can use, but several require equipment like a treadmill or a specially calibrated exercise cycle. It can be difficult to perform these tests and are not appropriate for all levels of fitness. Using a basic calculation or a walking/jogging test is the easiest way to calculate VO2 max. Calculate VO2 max using the following equation-
VO2 = 132.853 - (0.0769 x weight in-lb) - (0.3877 x age) + (6.315 x gender) - (3.2649 x walk time in minutes) - (0.156 x heart rate).
If you are male, use the number 1, if you are female, use the number 0 for the calculation (Kline, 1987; McSwegin, 1998).
Statistical Analysis
ANOVA with repeated measures, Friedman Test, Wilcox on test using appropriate statistics software was used for the statistical analysis.
Observation
Total 408 healthy subjects were screened, 114 subjects were enrolled for the study, 108 subjects completed the clinical trial and there were 6 subjects was drop out Table 1.
-
Among 408 screened subjects and 114 subjects were included in the study. Though the majority of 246 (60.30%) subjects were males and 162 (39.70%) subjects were females.
-
The age group of subjects showed that among 114, the majority of 112 (98.22%) subjects belonged to the age group of 18 to 25 completed years followed by 02 (1.75%) subjects belonged to 26-35 years.
-
Among 114 subjects, the majority of 102 (89.45%) had completed the schooling till PUC and 12 (10.52%) subjects were graduates.
-
Among 114 subjects, a majority of 84 (73.67%) subjects having joint family and 30 (26.33%) subjects having a nuclear family.
-
Among 114 subjects, majority of 70 (61.39%) subjects having poor housing condition, 32 (28.09%) subjects having moderate housing condition, 10 (8.77%) subjects having good housing condition and 02 (1.75%) having very good housing condition.
-
Among 114 subjects, all the subject having mixed food (vegetarian and non-vegetarian).
-
Among 114 subjects, majority 86 (75.44%) consume the food timely and 28 (24.56) consume untimely.
-
Among 114 subjects, majority 78 (68.40%) were of Vata Pitta Kapha Prakruti. A total of 15 (13.15%) belonged to Pitta Vata Kapha Prakruti, 02 (1.75%) each of Pitta Vata Kapha, Pitta Kapha Vata, Vata Kapha Pitta and 15 (13.15%) belonged to Kapha Vata Pitta Prakruti.
Source |
Type III Sum of Squares |
Df |
Mean Square |
F |
Sig. |
Partial Eta Squared |
|
---|---|---|---|---|---|---|---|
Time |
Sphericity Assumed |
3.353 |
2 |
1.676 |
11.936 |
<0.0001 |
.184 |
Greenhouse-Geisser |
3.353 |
1.503 |
2.230 |
11.936 |
<0.0001 |
.184 |
|
Huynh-Feldt |
3.353 |
1.538 |
2.180 |
11.936 |
<0.0001 |
.184 |
|
Lower-bound |
3.353 |
1.000 |
3.353 |
11.936 |
0.001 |
.184 |
|
Error (time) |
Sphericity Assumed |
14.887 |
106 |
.140 |
- |
- |
- |
Greenhouse-Geisser |
14.887 |
79.685 |
.187 |
- |
- |
- |
|
Huynh-Feldt |
14.887 |
81.501 |
.183 |
- |
- |
- |
|
Lower-bound |
14.887 |
53.000 |
.281 |
- |
- |
- |
(I) time |
(J) time |
Mean Difference (I-J) |
Std. Error |
Sig.b |
95% Confidence Interval for Difference |
|
---|---|---|---|---|---|---|
Lower Bound |
Upper Bound |
|||||
1 |
2 |
-.117 |
.051 |
0.079 |
-.243 |
.010 |
3 |
.230* |
.088 |
0.036 |
.012 |
.448 |
|
2 |
1 |
.117 |
.051 |
0.079 |
-.010 |
.243 |
3 |
.346* |
.072 |
<0.0001 |
.168 |
.525 |
|
3 |
1 |
-.230* |
.088 |
0.036 |
-.448 |
-.012 |
2 |
-.346* |
.072 |
<0.0001 |
-.525 |
-.168 |
Based on estimated marginal means *. The mean difference is significant at the .05 level. b. Adjustment for multiple comparisons: Bonferroni.
Results and Discussion
In the parameter, N was fixed to 54 in each group. The initial significance level considered in this study is 0.05. The subjects were analyzed at an interval of BT (Before intervention- i.e. on the baseline), AT (After the intervention, i.e. on 60th day) and FU (Follow up, i.e. 90 days).
Haemoglobin in the control group
Repeated measure ANOVA with Green house Geisser correction determined that mean hemoglobin differed statistically significantly between time points (F (1.503, 79.685) = 11.94, p<0.0001). Post hoc tests using Bonferroni correction revealed that administration of milk slight increase in Hemoglobin from before intervention to after intervention (13.43± 0.68gm/dl vs 13.54± 0.47 gm/dl respectively) in the control group, which was statistically significant (p< 0.0001) but no significant differences between after intervention and follow up (p=0.079).
However, after treatment had been reduced to 13.20± 0.51 gm/dl, which was not statistically significant to after intervention status of Hemoglobin (p=0.079) and to follow up Hemoglobin (p=0.036) (Table 4; Table 3; Table 2).
Therefore we can conclude that oral administration of milk (60 days) statistically significant in Hemoglobin from before intervention status to after intervention status, but not after follow up in the control group.
Haemoglobin |
N |
Mean |
Std. Deviation |
---|---|---|---|
Before intervention (0th day) |
54 |
13.2407 |
1.37601 |
After intervention (60th day) |
54 |
14.0130 |
.48605 |
Follow up (90th day ) |
54 |
14.1852 |
.58902 |
Source |
Type III Sum of Squares |
Df |
Mean Square |
F |
Sig. |
Partial Eta Squared |
|
---|---|---|---|---|---|---|---|
Time |
Sphericity Assumed |
27.323 |
2 |
13.662 |
20.675 |
<0.0001 |
.281 |
Greenhouse-Geisser |
27.323 |
1.116 |
24.489 |
20.675 |
<0.0001 |
.281 |
|
Huynh-Feldt |
27.323 |
1.123 |
24.338 |
20.675 |
<0.0001 |
.281 |
|
Lower-bound |
27.323 |
1.000 |
27.323 |
20.675 |
<0.0001 |
.281 |
|
Error (time) |
Sphericity Assumed |
70.043 |
106 |
.661 |
- |
- |
- |
Greenhouse-Geisser |
70.043 |
59.134 |
1.184 |
- |
- |
- |
|
Huynh-Feldt |
70.043 |
59.502 |
1.177 |
- |
- |
- |
|
Lower-bound |
70.043 |
53.000 |
1.322 |
- |
- |
- |
(I) time |
(J) time |
Mean Difference (I-J) |
Std. Error |
Sig.b |
95% Confidence Interval for difference |
|
---|---|---|---|---|---|---|
Lower Bound |
Upper Bound |
|||||
1 |
2 |
-.772* |
.180 |
<0.0001 |
-1.217 |
-.328 |
3 |
-.944* |
.195 |
<0.0001 |
-1.427 |
-.462 |
|
2 |
1 |
.772* |
.180 |
<0.0001 |
.328 |
1.217 |
3 |
-.172* |
.054 |
<0.0001 |
-.306 |
-.038 |
|
3 |
1 |
.944* |
.195 |
<0.0001 |
.462 |
1.427 |
2 |
.172* |
.054 |
0.008 |
.038 |
.306 |
Based on estimated marginal means *. The mean difference is significant at the .05 level. b. Adjustment for multiple comparisons: Bonferroni.
Hemoglobin in the study group
Repeated measure ANOVA with Green house Geisser correction determined that mean hemoglobin differed statistically significantly between time points (F (1.116, 59.134) = 20.675, p<0.0001). Post hoc tests using Bonferroni correction revealed that administration of Ashwagandha Churna with milk elicited an increase in Hemoglobin from before intervention to after intervention (13.24 ± 1.38 gm/ dl vs 14.01 ± 0.49 gm/dl), which was statistically significant (p< 0.0001). Also, the Hemoglobin during the follow up increased to 14.18± 0.59 gm/dl, which was statistically significant to after intervention status of Hemoglobin (p<0.0001) and to before intervention (p<0.0001) (Table 7; Table 6; Table 5). Therefore we can conclude that oral administration of Ashwagandha Churna (12gm) in a single dose with milk (60 days) elicits a statistically significant in Hemoglobin from before intervention status to after intervention status and follow up in study group.
VO2 max test |
N |
Mean |
Std. Deviation |
Min |
Max |
---|---|---|---|---|---|
Before intervention (0th day) |
54 |
2.6111 |
.52903 |
2.00 |
4.00 |
After intervention (60th day) |
54 |
2.2407 |
.43155 |
2.00 |
3.00 |
Follow up (90th day ) |
54 |
2.2778 |
.45211 |
2.00 |
3.00 |
VO2 max test |
N |
Mean rank |
X2 |
df |
P |
Remarks |
---|---|---|---|---|---|---|
Before intervention (0th day) |
54 |
2.35 |
33.091 |
2 |
<0.0001 |
S |
After intervention (60th day) |
54 |
1.80 |
||||
Follow up (90th day ) |
54 |
1.85 |
VO2 max test |
AT – BT |
FU – AT |
FU – BT |
---|---|---|---|
Z value |
-4.264b |
-1.414c |
-4.025b |
Asymp. Sig. (2-tailed)( P-value) |
<0.0001 |
0.157 |
<0.0001 |
Remarks |
S |
NS |
S |
a. Wilcoxon Signed Ranks Test, b. Based on positive ranks and c. Based on negative ranks.
VO2 max test |
N |
Mean |
Std. Deviation |
Min |
Max |
---|---|---|---|---|---|
Before intervention (0th day) |
54 |
2.8519 |
.40782 |
2.00 |
4.00 |
After intervention (60th day) |
54 |
2.1296 |
.61572 |
1.00 |
4.00 |
Follow up (90th day) |
54 |
2.1481 |
.56326 |
1.00 |
4.00 |
VO2 max test in the control group
There was a statistically significant difference in VO2 max test from BT (0th day) to AT (60th day) and FU (90th day), χ2 = 33.091, p< 0.0001. Post hoc analysis with Wilcoxon signed rank tests was applied to result and it also significantly changes. There was significant differences between BT (0th day) to AT (60th day) (Z = -4.264, p <0.0001), in between BT (0th day) to FU (90th day) (Z = -4.025, p <0.0001). There was no significant differences between AT (60th day) to FU (90th day) (Z = -1.414, p = 0.157) (Table 10; Table 9; Table 8)
VO2 max test in the study group
There was a statistically significant difference in VO2 max test from BT (0th day) to AT (60th day) and FU (90th day), χ2 = 74.150, p< 0.0001. Post hoc analysis with Wilcoxon signed rank tests was applied to result and it also significantly changes. There was significant differences between BT (0th day) to AT (60th day) (Z = -6.245, p <0.0001), in between BT (0th day) to FU (90th day) (Z = -6.164, p <0.000). There was no significant differences between AT (60th day) to FU (90th day) (Z = -0.577, p = 0.564) (Table 13; Table 12; Table 11).
Statistically, a significant increase in the hemoglobin study group compared to the control group. In the control group, hemoglobin means before intervention (13.43%), after the intervention (13.54%) and follow up (13.20). In the study group, hemoglobin means before intervention (13.24%), after the intervention (14.01%) and follow up (14.18%). Ashwagandha (WS) increased both the RBC and Hemoglobin count increase in RBC mass leads to increase in capacity of blood transport oxygen directly to exercising muscles, thereby enhancing the aerobic capacity (Ziauddin, 1996). Results indicate a significant (p< 0.05) improvement in the Maximal oxygen intake (VO2 max) test in the study group (Ashwagandha Choorna). Ashwagandha (WS) reduced oxidative stress, as various oxidants and improved level of diverse anti-oxidants (Choudhary, 2015).
VO2 max represent long term aerobic and cardio vascular endurance. Endurance training combined with a favorable genetic disposition, results in a series of physiological adaptations, designed to maximize endurance performance by increasing the amount of oxygen, which can be delivered to utilized by working muscle. Exercises that cause damage to the amount of different human body systems are long term strenuous free radical release. Increased lipid peroxidation may be caused by stress, whereas catalase and glutathione peroxidase enzymes minimize antioxidant levels.
VO2 max test |
N |
Mean rank |
X2 |
Df |
P |
Remarks |
---|---|---|---|---|---|---|
Before intervention (0th day) |
54 |
2.71 |
74.150 |
2 |
<0.0001 |
S |
After intervention (60th day) |
54 |
1.63 |
||||
Follow up (90th day) |
54 |
1.66 |
VO2 max test |
AT – BT |
FU – AT |
FU – BT |
---|---|---|---|
Z value |
-6.245b |
-.577c |
-6.164b |
Asymp. Sig. (2-tailed)(P-value) |
<0.0001 |
0.564 |
<0.0001 |
Remarks |
S |
NS |
S |
a. Wilcoxon signed ranks test, b. Based on positive ranks and c. Based on negative ranks.
All the parameters of free harm are standardized in a dose dependent manner when researchers administered Ashwagandha (WS) one hour prior to daily stress inducing therapy (Bhattacharya & Muruganandam, 2003).
Ashwagandha (Withania Somnifera) chemical constituents such as flavonoids, alkaloids, and steroidal lactones (withanolides) or antioxidants (superoxide dismutase, catalase and glutathione peroxidase) may be behind VO2 max improvement. In healthy adults and also in athletes, Ashwagandha also enhances cardiovascular fitness, providing an additional alternative as a dietary supplement to boost the VO2 max measure (Choudhary, 2015; Dhuley, 1998).
The active principles of Ashwagandha (WS), VII-X sitondosides and withaferin A (glycowwithanolides) have been evaluated for antioxidant activity using the major free radical scavenging enzymes in the frontal cortex and striatum of the rat brain, superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX) (Dhuley, 1998).
Conclusions
Ashwagandha (WS) an important herb in Ayurveda, the traditional Indian system medicine is considered to be a Rasayana (rejuvenating). In this study, oral administration of Ashwagandha (Withania Somnifera) with milk enhanced VO2 max (maximum aerobic capacity) and increased hemoglobin in healthy subjects. The finding of this study suggests that Ashwagandha improves cardiovascular dynamics by increasing VO2 max levels, thereby enhancing cardiorespiratory endurance and also increases hemoglobin in healthy subjects.